The legacy of Viagra offers a intricate case study for stakeholders eyeing pharma. While early sales were remarkable, current patent lapse and the arrival of generic versions have significantly affected revenues. In https://carlyzpwf020369.iyublog.com/39823474/the-blue-pill-and-pharma-a-dangerous-stake